Article
Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins
4 Mar 2020
Abstract excerpt
Background: We previously reported that cannabidiol (CBD), a cannabinoid with a low toxicity profile, downregulated the expression of the prometastatic gene inhibitor of DNA binding 1 ( ID1 ) in cancer cells, leading to inhibition of tumor progression in vivo . While CBD is broadly used, including in the self-medication of cancer patients, and CBD-based therapies are undergoing clinical evaluation for cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
